Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
| Current Price | ₹1,395.90 |
|---|---|
| Market Cap | ₹29,513 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services > Pharmaceutical CDMO and CRO Services |
| P/E Ratio | 85 |
| Return on Equity | 15.13% |
| 52-Week Range | ₹783.85 – ₹1,697.00 |
| Beta (1Y) | 0.44 |
| Revenue | ₹554 Cr |
|---|---|
| Net Profit | ₹73 Cr |
| EPS (Basic) | ₹3.46 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Contract Research, Development and Manufacturing Services (CRDMO)-100%
Sai Life Sciences Limited is trading at ₹1,395.90, with a market capitalisation of ₹29,513 Cr.
Sai Life Sciences Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services > Pharmaceutical CDMO and CRO Services).
Sai Life Sciences Limited has a P/E of 85 and a return on equity of 15.13%.
In Q1 FY27, Sai Life Sciences Limited reported revenue of ₹554 Cr and net profit of ₹73 Cr, with basic EPS of ₹3.46 (consolidated, parsed from the company's exchange filing).